Akinfemiwa, O., Zubair, M., & Muniraj, T
Your safety and well-being are our top priorities, and we are always here to support you throughout your health journey
Even simple physical tasks may feel disproportionately draining because cells cannot generate adequate ATP
Ltd (Batch#10,100,420,190,605) and packed by Zenta Pharmaceutical Company
Key Benefits Observed in Clinical Trials Treatment of Erythropoietic Protoporphyria (EPP): MT-1 (Afamelanotide) is FDA-approved for use in patients with EPP, a rare genetic disorder that causes extreme photosensitivity, leading to severe pain and skin damage upon light exposure
Practical Considerations Favoring Oral Delivery: Beyond bioavailability questions, oral administration offers significant lifestyle advantages that make peptide therapy accessible to a broader population: No Injection Requirement: Many individuals interested in tissue support supplementation are deterred by injection protocols